San Francisco, CA (PRWEB) May 26, 2021 HomeLight, the real estate technology platform transforming the home buying and selling process for the top real
RightBound, a Kirkland WA- and Tel Aviv, Israel-based based sales prospecting engine company, raised $12M in Series A funding.
The round was led by Innovation Endeavors with participation from IBI Tech Fund, Operator Collective and existing angel investors Zach Weinberg, Nat Turner, and Gil Shklarski.
The company intends to use the funds to expand operations and its business reach.
Founded by Ran Oelgiesser and Rotem Dafni, RightBound is a technology company that has created an autonomous sales prospecting engine. The company automatically completes the manual account research on the rep’s behalf, conducts personalized outreach to prospects across multiple channels, and connects teams with relevant, engaged buyers. The RightBound machine connects with Salesforce, SalesLoft, Outreach.io and Hubspot.
Struum launches its ‘ClassPass for streaming’ service to the public
Struum, the new streaming service from former Disney and Discovery execs, is today officially launching to the public. Unlike traditional on-demand streamers, such as Netflix, the Struum model is more akin to a “ClassPass for streaming,” as its plan is to aggregate content from smaller video services then provide access under its own subscription.
Today, the streaming landscape is dominated by larger subscription services, including Netflix, Hulu, Amazon Prime Video, Apple TV+, HBO Max, Disney+, and YouTube, who together have a 75% share of the market, according to Nielsen. But Struum believes there’s a potential for another service powered by the long tail of the over 250 niche and speciality streamers.
With the growing number of streaming services, viewers have an unprecedented level of choice over what they want to watch. But they also face the daunting task of keeping all those services straight. Not to mention the growing cost.
A cadre of former Disney and Discovery executives has proposed a so
Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center
Thermo Fisher Scientific Inc. the world leader in serving science, and the University of California, San Francisco today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the agreement, Thermo Fisher will build and operate a 44,000-square-foot, state-of-the-art cell therapy development, manufacturing and collaboration center in leased space …
– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies.